» Articles » PMID: 23164426

Roles of MicroRNA on Cancer Cell Metabolism

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2012 Nov 21
PMID 23164426
Citations 99
Authors
Affiliations
Soon will be listed here.
Abstract

Advanced studies of microRNAs (miRNAs) have revealed their manifold biological functions, including control of cell proliferation, cell cycle and cell death. However, it seems that their roles as key regulators of metabolism have drawn more and more attention in the recent years. Cancer cells display increased metabolic autonomy in comparison to non-transformed cells, taking up nutrients and metabolizing them in pathways that support growth and proliferation. MiRNAs regulate cell metabolic processes through complicated mechanisms, including directly targeting key enzymes or transporters of metabolic processes and regulating transcription factors, oncogenes / tumor suppressors as well as multiple oncogenic signaling pathways. MiRNAs like miR-375, miR-143, miR-14 and miR-29b participate in controlling cancer cell metabolism by regulating the expression of genes whose protein products either directly regulate metabolic machinery or indirectly modulate the expression of metabolic enzymes, serving as master regulators, which will hopefully lead to a new therapeutic strategy for malignant cancer. This review focuses on miRNA regulations of cancer cell metabolism,including glucose uptake, glycolysis, tricarboxylic acid cycle and insulin production, lipid metabolism and amino acid biogenesis, as well as several oncogenic signaling pathways. Furthermore, the challenges of miRNA-based strategies for cancer diagnosis, prognosis and therapeutics have been discussed.

Citing Articles

FOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinoma.

Hsu T, Wang W, Chen H, Wang T, Su C, Liao P Cancer Metab. 2025; 13(1):7.

PMID: 39930542 PMC: 11809001. DOI: 10.1186/s40170-025-00377-3.


Deciphering the multifaceted role of microRNAs in hepatocellular carcinoma: Integrating literature review and bioinformatics analysis for therapeutic insights.

Rahdan F, Saberi A, Saraygord-Afshari N, Hadizadeh M, Fayeghi T, Ghanbari E Heliyon. 2024; 10(20):e39489.

PMID: 39498055 PMC: 11532857. DOI: 10.1016/j.heliyon.2024.e39489.


miR-4448/Girdin/Akt/AMPK axis inhibits EZH2-mediated EMT and tumorigenesis in small-cell lung cancer.

Koyama N, Ishikawa Y, Ohta H, Aoki T, Kyoyama H, Aoshiba K Cancer Med. 2024; 13(19):e70093.

PMID: 39400978 PMC: 11476246. DOI: 10.1002/cam4.70093.


MicroRNAs in metabolism for precision treatment of lung cancer.

Carra G, Petiti J, Tolino F, Vacca R, Orso F Cell Mol Biol Lett. 2024; 29(1):121.

PMID: 39256662 PMC: 11384722. DOI: 10.1186/s11658-024-00632-3.


MicroRNA-16 inhibits the growth and metastasis of human glioma cells via modulation of PI3K/AKT/mTOR signalling pathway.

Yang Y, Zhao F Arch Med Sci. 2024; 20(3):839-846.

PMID: 39050153 PMC: 11264078. DOI: 10.5114/aoms.2020.95653.


References
1.
Iliopoulos D, Drosatos K, Hiyama Y, Goldberg I, Zannis V . MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res. 2010; 51(6):1513-23. PMC: 3035515. DOI: 10.1194/jlr.M004812. View

2.
Trajkovski M, Hausser J, Soutschek J, Bhat B, Akin A, Zavolan M . MicroRNAs 103 and 107 regulate insulin sensitivity. Nature. 2011; 474(7353):649-53. DOI: 10.1038/nature10112. View

3.
Wilfred B, Wang W, Nelson P . Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol Genet Metab. 2007; 91(3):209-17. PMC: 1978064. DOI: 10.1016/j.ymgme.2007.03.011. View

4.
Vander Heiden M, Locasale J, Swanson K, Sharfi H, Heffron G, Amador-Noguez D . Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science. 2010; 329(5998):1492-9. PMC: 3030121. DOI: 10.1126/science.1188015. View

5.
Lovis P, Roggli E, Laybutt D, Gattesco S, Yang J, Widmann C . Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes. 2008; 57(10):2728-36. PMC: 2551683. DOI: 10.2337/db07-1252. View